(Post-pandemic Era)-Global Human Growth Hormone Drugs Market Assessment, With Major Companies Analysis, Regional Analysis, Breakdown Data by Application/Type 2023

Report ID: 270647 | Published Date: Jan 2025 | No. of Page: 83 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Table of Contents

Global Human Growth Hormone Drugs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
    1.1 Product Details and Introduction
      1.1.1 Norditropin -Product Introduction and Major Manufacturers
      1.1.2 Genotropin -Product Introduction and Major Manufacturers
      1.1.3 Humatrope -Product Introduction and Major Manufacturers
      1.1.4 Saizen -Product Introduction and Major Manufacturers
      1.1.5 Omnitrope - the Somatropin Biosimilar -Product Introduction and Major Manufacturers
      1.1.6 Somatropin Biopartners -Product Introduction and Major Manufacturers
    1.2 Market Snapshot
      1.2.1 Major Companies Overview
      1.2.2 Market Concentration
      1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
    2.1 Regional Market Share in Terms of Production (2020-2027)
    2.2 Regional Market Share in Terms of Revenue (2020-2027)
    2.3 Regional Market Share in Terms of Consumption (2020-2027)
3 Global Human Growth Hormone Drugs Market Assessment by Type
    3.1 Global Human Growth Hormone Drugs Production by Type (2016-2027)
    3.2 Global Human Growth Hormone Drugs Revenue by Type (2016-2027)
    3.3 North America Human Growth Hormone Drugs Production and Revenue by Type (2016-2027)
    3.4 Asia Human Growth Hormone Drugs Production and Revenue by Type (2016-2027)
    3.5 Europe Human Growth Hormone Drugs Production and Revenue by Type (2016-2027)
    3.6 Middle East & Africa Human Growth Hormone Drugs Production and Revenue by Type (2016-2027)
    3.7 South America Human Growth Hormone Drugs Production and Revenue by Type (2016-2027)

4 Global Human Growth Hormone Drugs Market Assessment by Application
    4.1 Historical & Forecast Global Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)
    4.2 Historical & Forecast North America Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)
    4.3 Historical & Forecast Asia Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)
    4.4 Historical & Forecast Europe Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)
    4.5 Historical & Forecast Middle East & Africa Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)
    4.6 Historical & Forecast South America Human Growth Hormone Drugs Consumption, Different Application Field (2016-2027)

5 North America
    5.1 US Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.2 Canada Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    5.3 Mexico Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
6 Asia
    6.1 China Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.2 Japan Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.3 India Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.4 Korea Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    6.5 Southeat Asia Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
7 Europe
    7.1 Germany Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.2 UK Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.3 France Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.4 Russia Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    7.5 Italy Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
8 Middle East and Africa
    8.1 Saudi Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.2 UAE Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.3 Egypt Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.4 Nigeria Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    8.5 South Africa Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
9 South America
    9.1 Brazil Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.2 Argentina Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
    9.3 Colombia Human Growth Hormone Drugs Capacity, Production, Consumption and Proportion of Products Sold (2016-2027)
10 Global Human Growth Hormone Drugs Average Price Trend
    10.1 Market Price for Each Type of Human Growth Hormone Drugs in North America (2016-2027)
    10.2 Market Price for Each Type of Human Growth Hormone Drugs in Asia (2016-2027)
    10.3 Market Price for Each Type of Human Growth Hormone Drugs in Europe (2016-2027)
    10.4 Market Price for Each Type of Human Growth Hormone Drugs in Middle East & Africa (2016-2027)
    10.5 Market Price for Each Type of Human Growth Hormone Drugs in South America (2016-2027)

11 Value Chain (Impact of COVID-19)
    11.1 Human Growth Hormone Drugs Value Chain Analysis
      11.1.1 Upstream
      11.1.2 Downstream
    11.2 COVID-19 Impact on Human Growth Hormone Drugs Industry
      11.2.1 Industrial Policy Issued Under the Epidemic Situation
    11.3 Cost-Under the Epidemic Situation
      11.3.1 Cost of Raw Material
    11.4 Channel Analysis
      11.4.1 Distribution Channel-Under the Epidemic Situation
      11.4.2 Distributors

12 Human Growth Hormone Drugs Competitive Analysis
     12.1 Eli Lilly and Company (US)
        12.1.1 Eli Lilly and Company (US) Company Profiles
        12.1.2 Eli Lilly and Company (US) Product Introduction
        12.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.1.4 SWOT Analysis
     12.2 Ferring Holding SA (Switzerland)
        12.2.1 Ferring Holding SA (Switzerland) Company Profiles
        12.2.2 Ferring Holding SA (Switzerland) Product Introduction
        12.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.2.4 SWOT Analysis
     12.3 Genentech, Inc. (US)
        12.3.1 Genentech, Inc. (US) Company Profiles
        12.3.2 Genentech, Inc. (US) Product Introduction
        12.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.3.4 SWOT Analysis
     12.4 GeneScience Pharmaceuticals Co., Ltd. (China)
        12.4.1 GeneScience Pharmaceuticals Co., Ltd. (China) Company Profiles
        12.4.2 GeneScience Pharmaceuticals Co., Ltd. (China) Product Introduction
        12.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.4.4 SWOT Analysis
        12.5.1 Merck KgaA (Germany) Company Profiles
        12.5.2 Merck KgaA (Germany) Product Introduction
        12.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.5.4 SWOT Analysis
     12.6 Novo Nordisk A/S (Denmark)
        12.6.1 Novo Nordisk A/S (Denmark) Company Profiles
        12.6.2 Novo Nordisk A/S (Denmark) Product Introduction
        12.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.6.4 SWOT Analysis
     12.7 Pfizer, Inc. (US)
        12.7.1 Pfizer, Inc. (US) Company Profiles
        12.7.2 Pfizer, Inc. (US) Product Introduction
        12.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.7.4 SWOT Analysis
     12.8 Sandoz International GmbH (Germany)
        12.8.1 Sandoz International GmbH (Germany) Company Profiles
        12.8.2 Sandoz International GmbH (Germany) Product Introduction
        12.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Production, Revenue (2015-2020)
        12.8.4 SWOT Analysis
13 Conclusion


List of Tables and Figures

    Figure Product Introduction
    Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2020)
    Figure Global Human Growth Hormone Drugs Production Market Share of Top 5 Players
    Table CAGR of Major Market (2021-2026)
    Table CAGR in Terms of Production of Each Type (2016-2027)
    Table Regional Market Share in Terms of Production (2020-2027)
    Figure Regional Market Share in Terms of Production (2019 - 2020)
    Table Regional Market Share in Terms of Revenue (2020-2027)
    Figure Regional Market Share in Terms of Revenue (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Figure Regional Market Share in Terms of Consumption (2019 - 2020)
    Table Global Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure Global Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure Global Human Growth Hormone Drugs Production Market Share (%) by Type (2019 -2020)
    Table Global Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure Global Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Global Human Growth Hormone Drugs Revenue Market Share (%) by Type (2019-2020)
    Figure North America Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure North America Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure North America Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure North America Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Asia Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure Asia Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure Asia Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure Asia Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Europe Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure Europe Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure Europe Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure Europe Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Figure Middle East & Africa Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure Middle East & Africa Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure Middle East & Africa Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Figure South America Human Growth Hormone Drugs Production (K Unit) by Type (2016-2027)
    Figure South America Human Growth Hormone Drugs Production (K Unit) and Growth Rate (2016-2027)
    Figure South America Human Growth Hormone Drugs Revenue (Million USD) by Type (2016-2027)
    Figure South America Human Growth Hormone Drugs Revenue (Million USD) and Growth Rate (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Different Application Field Consumption Market Share (%) (2019-2020)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure North America Human Growth Hormone Drugs Consumption (K Unit) and Growth Rate (2016-2027)
    Figure North America Human Growth Hormone Drugs Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure Asia Human Growth Hormone Drugs Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Asia Human Growth Hormone Drugs Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure Europe Human Growth Hormone Drugs Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Europe Human Growth Hormone Drugs Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure Middle East & Africa Human Growth Hormone Drugs Consumption (K Unit) and Growth Rate (2016-2027)
    Figure Middle East & Africa Human Growth Hormone Drugs Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Figure South America Human Growth Hormone Drugs Consumption (K Unit) and Growth Rate (2016-2027)
    Figure South America Human Growth Hormone Drugs Consumption Market Share (%) by Application (2016-2027)
    Table Historical & Forecast Human Growth Hormone Drugs Different Application Field Consumption (K Unit)
    Table US Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Canada Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Mexico Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table China Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Japan Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table India Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Korea Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Southeast Asia Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Germany Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UK Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table France Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Russia Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Italy Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Saudi Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table UAE Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Egypt Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Nigeria Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table South Africa Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Brazil Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Argentina Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Colombia Human Growth Hormone Drugs Capacity (K Units), Production (K Units) and Consumption (K Units) (2016-2027) and Proportion of Products Sold
    Figure Proportion of Products Sold (%) (2015 -2026)
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in China
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in EU
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in USA
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in Japan
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in India
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in Southeast Asia
    Table Market Price (USD/Unit) for Each Type of Human Growth Hormone Drugs in South America
    Figure Value Chain Structure of Human Growth Hormone Drugs
    Table Value Chain
    Table Key Suppliers of Raw Material/Components
    Table Key Downstream Customer in Each Application Field
    Table Industry News List of Human Growth Hormone Drugs
    Figure Cost Structure of Human Growth Hormone Drugs in 2020
    Table Distributors/Traders List
    Table Eli Lilly and Company (US) Profiles
    Table Eli Lilly and Company (US) Human Growth Hormone Drugs Product Introduction
    Figure Eli Lilly and Company (US) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Eli Lilly and Company (US) SWOT Analysis
    Table Ferring Holding SA (Switzerland) Profiles
    Table Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Product Introduction
    Figure Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Ferring Holding SA (Switzerland) SWOT Analysis
    Table Genentech, Inc. (US) Profiles
    Table Genentech, Inc. (US) Human Growth Hormone Drugs Product Introduction
    Figure Genentech, Inc. (US) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Genentech, Inc. (US) SWOT Analysis
    Table GeneScience Pharmaceuticals Co., Ltd. (China) Profiles
    Table GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Product Introduction
    Figure GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure GeneScience Pharmaceuticals Co., Ltd. (China) SWOT Analysis
    Table Merck KgaA (Germany) Profiles
    Table Merck KgaA (Germany) Human Growth Hormone Drugs Product Introduction
    Figure Merck KgaA (Germany) Medical Devices & Consumables Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Merck KgaA (Germany) SWOT Analysis
    Table Novo Nordisk A/S (Denmark) Profiles
    Table Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Product Introduction
    Figure Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Novo Nordisk A/S (Denmark) SWOT Analysis
    Table Pfizer, Inc. (US) Profiles
    Table Pfizer, Inc. (US) Human Growth Hormone Drugs Product Introduction
    Figure Pfizer, Inc. (US) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)
    Figure Pfizer, Inc. (US) SWOT Analysis
    Table Sandoz International GmbH (Germany) Profiles
    Table Sandoz International GmbH (Germany) Human Growth Hormone Drugs Product Introduction
    Figure Sandoz International GmbH (Germany) Human Growth Hormone Drugs Capacity (Unit), Production (Unit), Revenue (Million USD) (2015-2020)

Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
-Global Human Growth Hormone Drugs Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
-Global Human Growth Hormone Drugs Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
-Global Human Growth Hormone Drugs Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports